Gastroenterology
Volume 124, Issue 4 , Pages 894-902, April 2003

Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease☆☆

Part of this work was presented at the American Gastroenterological Association meeting in May 2002 and published in abstract form (Gastroenterology 2002;122:A418).

  • Thierry Piche

      Affiliations

    • CIC INSERM and U 539-Centre Hospitalier Universitaire-Hôtel Dieu, Nantes, France
  • ,
  • Stanislas Bruley des Varannes

      Affiliations

    • CIC INSERM and U 539-Centre Hospitalier Universitaire-Hôtel Dieu, Nantes, France
  • ,
  • Sylvie Sacher-Huvelin

      Affiliations

    • CIC INSERM and U 539-Centre Hospitalier Universitaire-Hôtel Dieu, Nantes, France
  • ,
  • Jens Juul Holst

      Affiliations

    • Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen, Denmark
  • ,
  • Jean Claude Cuber

      Affiliations

    • INSERM U 45, Hôpital Edouard Herriot, Pavillon Hbis, Lyon, France
  • ,
  • Jean Paul Galmiche

      Affiliations

    • CIC INSERM and U 539-Centre Hospitalier Universitaire-Hôtel Dieu, Nantes, France

Received 6 August 2002; accepted 9 January 2003.

Abstract 

Background & Aims: Colonic fermentation of carbohydrates is known to influence gastric and esophageal motility in healthy subjects. This study investigated the effects of colonic fermentation induced by oral administration of fructooligosaccharides (FOS) in patients with gastroesophageal reflux disease (GERD). Methods: In the cross-over design used in the study, 9 patients with symptomatic GERD were administered a low-residue diet (i.e., 10 g fiber/day) during 2, 7-day periods, receiving either 6.6 g of FOS or placebo 3 times daily after meals. Each period was separated by a wash out of at least 3 weeks. On day 7, esophageal motility and pH were recorded in fasting conditions and after a test meal containing 6.6 g of FOS or placebo. Breath hydrogen concentrations (reflecting colonic fermentation) and plasma concentrations of glucagon-like peptide 1 (GLP-1), peptide YY, and cholecystokinin were monitored. Results: Compared with placebo, FOS led to a significant increase in the number of transient lower esophageal sphincter relaxations (TLESRs) and reflux episodes, esophageal acid exposure, and the symptom score for GERD. The integrated plasma response of GLP-1 was significantly higher after FOS than placebo. Conclusions: Colonic fermentation of indigestible carbohydrates increases the rate of TLESRs, the number of acid reflux episodes, and the symptoms of GERD. Although different mechanisms are likely to be involved, excess release of GLP-1 may account, at least in part, for these effects.

Abbreviations:  CCK , cholecystokinin, FOS , fructooligosaccharides, GERD , gastroesophageal reflux disease, GLP-1 , glucagon-like peptide 1, H2, hydrogen, LES , lower esophageal sphincter, PYY , peptide YY, SCFAs , short chain fatty acids, TLESR , transient lower esophageal sphincter relaxation

 

 Address requests for reprints to: Jean Paul Galmiche, M.D., CIC INSERM and U 539-Centre Hospitalier Universitaire-Hôtel Dieu, 44093 Nantes Cedex 1, France. e-mail: galmiche@easynet.fr; fax: (33) 2 40083168.

☆☆ 0016-5085/03/$30.00

PII: S0016-5085(03)00073-8

Gastroenterology
Volume 124, Issue 4 , Pages 894-902, April 2003